Liver transplantation for hepatocellular carcinoma: Where do we stand?

查看全文 作　　者：Francesco [1]Santopaolo;Ilaria [1]Lenci;Martina [1]Milana;Tommaso Maria [2]Manzia;Leonardo [1]Baiocchi

机构地区：[1]Hepatology Unit,Department of Medicine,Policlinico Universitario Tor Vergata,Rome 00133,Italy;[2]Transplant Surgery Unit,Department of Surgery,Policlinico Universitario Tor Vergata,Rome 00133,Italy

出　　处：《World Journal of Gastroenterology》索引2019年第25卷第21期,共12页

摘　　要：Hepatocellular carcinoma represents an important cause of morbidity and mortality worldwide. It is the sixth most common cancer and the fourth leading cause of cancer death. Liver transplantation is a key tool for the treatment of this disease in human therefore hepatocellular carcinoma is increasing as primary indication for grafting. Although liver transplantation represents an outstanding therapy for hepatocellular carcinoma, due to organ shortage, the careful selection and management of patients who may have a major survival benefit after grafting remains a fundamental question. In fact, only some stages of the disease seem amenable of this therapeutic option, stimulating the debate on the appropriate criteria to select candidates. In this review we focused on current criteria to select patients with hepatocellular carcinoma for liver transplantation as well as on the strategies (bridging) to avoid disease progression and exclusion from grafting during the stay on wait list. The treatments used to bring patients within acceptable criteria (down-staging), when their tumor burden exceeds the standard criteria for transplant, are also reported. Finally, we examined tumor reappearance following liver transplantation. This occurrence is estimated to be approximately 8%-20% in different studies. The possible approaches to prevent this outcome after transplant are reported with the corresponding results. 关键词：HEPATOCELLULAR carcinoma Liver transplantation BRIDGING Down-staging MILAN Criteria

相关文献

参考文献（95）
引证文献（22）
耦合文献（0）

参考文献(95)

引证文献(22)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Liver transplantation for hepatocellular carcinoma: Where do we stand?

参考文献(95)

引证文献(22)

用户提示